Drug Profile
Rotavirus vaccine trivalent - Lanzhou Institute of Biological Products
Alternative Names: Trivalent genetic reassortant rotavirus vaccine - Lanzhou Institute of Biological ProductsLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Lanzhou Institute of Biological Products
- Class Rotavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Rotavirus infections
Most Recent Events
- 28 Dec 2018 No recent reports of development identified for clinical-Phase-Unknown development in Rotavirus-infections(Prevention) in China (PO, Liquid)
- 25 Nov 2015 Clinical trials in Rotavirus infections (Prevention) in China (PO)